Literature DB >> 15158199

What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells?

Karina R B Bastos1, Claudio R F Marinho, Renato Barboza, Momtchilo Russo, José M Alvarez, Maria Regina D'Império Lima.   

Abstract

The present review illustrates the current knowledge on the autocrine effect of IL-12, and the putative contribution of IL-23, on macrophages and dendritic cells, focusing on cell activation and microbicidal activity. Here, we present convincing evidence that IL-12 is not only a connective element between accessory cells and lymphocytes, but it is also a key molecule for programming the macrophage and dendritic cell functions.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15158199     DOI： 10.1016/j.micinf.2004.02.012

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  21 in total

1.  Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.

Authors:  James M Miller; Sarah McNulty Bidula; Troels Mygind Jensen; Carol Shoshkes Reiss
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2010-05-01

2.  Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.

Authors:  Teresa M Wozniak; Anthony A Ryan; James A Triccas; Warwick J Britton
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice.

Authors:  Karina R B Bastos; Luciana de Deus Vieira de Moraes; Cláudia A Zago; Cláudio R F Marinho; Momtchilo Russo; José M M Alvarez; Maria R D'Império Lima
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

4.  Dual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors.

Authors:  Zhen Huang; Junting Ma; Mengjie Chen; Haoyang Jiang; Yong Fu; Jingjing Gan; Lei Dong; Junfeng Zhang; Jiangning Chen
Journal:  Mol Ther       Date:  2015-06-15       Impact factor: 11.454

5.  Cytokine-modified VSV is attenuated for neural pathology, but is both highly immunogenic and oncolytic.

Authors:  James Miller; Sarah M Bidula; Troels M Jensen; Carol Shoshkes Reiss
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2009-12-01

6.  Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response.

Authors:  M L V Watkins; P L Semple; B Abel; W A Hanekom; G Kaplan; S R Ress
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

7.  Anti-TNF-alpha therapy does not ameliorate disease in a model of acute virus-endotoxin mediated respiratory disease in pigs.

Authors:  Kalina Atanasova; Steven Van Gucht; Kristien Van Reeth
Journal:  Vet Immunol Immunopathol       Date:  2010-04-13       Impact factor: 2.046

8.  Lipoteichoic acid from Staphylococcus aureus exacerbates respiratory disease in porcine respiratory coronavirus-infected pigs.

Authors:  Kalina Atanasova; Steven Van Gucht; Filip Barbé; Luc Duchateau; Kristien Van Reeth
Journal:  Vet J       Date:  2010-04-20       Impact factor: 2.688

9.  Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers.

Authors:  Tricia L Humphreys; Lang Li; Xiaoman Li; Diane M Janowicz; Kate R Fortney; Qianqian Zhao; Wei Li; Jeanette McClintick; Barry P Katz; David S Wilkes; Howard J Edenberg; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

10.  Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.

Authors:  Rishein Gupta; Harsh Vardhan; Pragya Srivastava; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-08-22       Impact factor: 5.211
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.